Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 842

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 842
---
 of 
    people |     |    USD in 
 thousands |
| Short-term employee benefits |     |                       4 |     |       355 |     |         4 |     |       752 |     |         6 |     |     1,234 |
| Share-based payment          |     |                       1 |     |        42 |     |         1 |     |        75 |     |         3 |     |       149 |
|                              |     |                         |     |       397 |     |           |     |       827 |     |           |     |     1,383 |

Annex G-42

KADIMASTEM LTD.
NOTES TO FINANCIAL STATEMENTS Note 22: — BALANCES AND TRANSACTIONS WITH interested AND RELATED PARTIES (cont.) 2.Compensation of office holders and interested parties (including directors) who are not employed by the Company:

|                      |     | Year that ended December 31, |     |           |     |           |     |           |     |           |     |           |
|                      |     |                         2024 |     |           |     |      2023 |     |           |     |      2022 |     |           |
|                      |     |                       Amount |     |           |     |    Amount |     |           |     |    Amount |     |           |
|                      |     |                    Number of 
                       people |     |    USD in 
 thousands |     | Number of 
    people |     |    USD in 
 thousands |     | Number of 
    people |     |    USD in 
 thousands |
| Short-term benefits* |     |                            5 |     |       325 |     |         9 |     |       176 |     |        11 |     |       219 |
| Share-based payment  |     |                            1 |     |       166 |     |         1 |     |        55 |     |         1 |     |       202 |
|                      |     |                              |     |       491 |     |           |     |       231 |     |           |     |       421 |

____________ *Of this amount, benefits in respect of directors amount to approx. USD $48 thousand. 3.The Company’s Chief Scientist, who is also an interested party, provides services to the Company for no consideration (see section b